logo
explain how to read the page

The above diagram shows the color scheme of the layout in the main result page. The parent entities and officers are those entities, including individual and legal persons, have significant controls over the company in focus. The offspring entities and appointments are those entities that the company in focus can influence on.

Clicking the links on parent entities or officers, and offspring entities or managed companies will put them in focus and show upstream or downstream connections. In general, ascendant entities can be found by moving toward upstream, and descendant entities are by toward downstream. In this way, progenitor entities such as grandparent companies (parents of parent), sibling companies (children of parent), partner companies (parents of child), and progeny entities such as grandchild companies (children of child) can be found easily.

Parent entities and officers
Active 4
  • 1
    Evans, Jeanette
    Born in March 1969
    Individual (2 offsprings)
    Officer
    icon of calendar 2024-05-09 ~ now
    OF - Director → CIF 0
  • 2
    Papenfuss, Kerstin, Dr
    Born in May 1982
    Individual (5 offsprings)
    Officer
    icon of calendar 2023-10-24 ~ now
    OF - Director → CIF 0
  • 3
    Matjusaitis, Mantas, Dr
    Born in December 1990
    Individual (3 offsprings)
    Officer
    icon of calendar 2024-01-04 ~ now
    OF - Director → CIF 0
    Dr Mantas Matjusaitis
    Born in December 1990
    Individual (3 offsprings)
    Person with significant control
    icon of calendar 2024-01-16 ~ now
    PE - Ownership of shares – More than 25% but not more than 50%CIF 0
    PE - Ownership of voting rights - More than 25% but not more than 50%CIF 0
  • 4
    Djordjevic, Djordje, Dr
    Born in April 1988
    Individual (1 offspring)
    Officer
    icon of calendar 2024-01-04 ~ now
    OF - Director → CIF 0
    Dr Djordje Djordjevic
    Born in April 1988
    Individual (1 offspring)
    Person with significant control
    icon of calendar 2024-01-16 ~ now
    PE - Ownership of voting rights - More than 25% but not more than 50%CIF 0
    PE - Ownership of shares – More than 25% but not more than 50%CIF 0
Ceased 3
  • 1
    Appleby, Jonathan Mark, Dr
    Chief Scientific Officer, Medicines Development born in February 1971
    Individual
    Officer
    icon of calendar 2023-10-24 ~ 2024-05-09
    OF - Director → CIF 0
  • 2
    icon of addressCell And Gene Therapy Catapult, 12th Floor Tower Wing, Guy’s Hospital, Great Maze Pond, London, United Kingdom
    Active Corporate (4 parents)
    Person with significant control
    2023-10-24 ~ 2024-01-16
    PE - Right to appoint or remove directorsCIF 0
    PE - Ownership of voting rights - More than 25% but not more than 50%CIF 0
    PE - Ownership of shares – More than 25% but not more than 50%CIF 0
  • 3
    icon of addressC/o Deep Science Ventures, 45-54 High Street, Ingatestone, United Kingdom
    Active Corporate (3 parents, 7 offsprings)
    Equity (Company account)
    327,065 GBP2020-08-31
    Person with significant control
    2023-10-24 ~ 2024-01-16
    PE - Ownership of shares – More than 25% but not more than 50%CIF 0
    PE - Right to appoint or remove directorsCIF 0
    PE - Ownership of voting rights - More than 25% but not more than 50%CIF 0
parent relation
Company in focus

PLURIFY LTD

Standard Industrial Classification
72110 - Research And Experimental Development On Biotechnology
Brief company account
Average Number of Employees
52023-10-24 ~ 2024-12-31
02022-10-24 ~ 2023-10-23
Property, Plant & Equipment
14,586 GBP2024-12-31
Fixed Assets
14,586 GBP2024-12-31
Debtors
Current
74,731 GBP2024-12-31
Cash at bank and in hand
362,293 GBP2024-12-31
Current Assets
437,024 GBP2024-12-31
Net Current Assets/Liabilities
13,073 GBP2024-12-31
Total Assets Less Current Liabilities
27,659 GBP2024-12-31
Creditors
Non-current, Amounts falling due after one year
-40,000 GBP2024-12-31
Net Assets/Liabilities
-12,341 GBP2024-12-31
Equity
Called up share capital
116 GBP2024-12-31
Share premium
309,952 GBP2024-12-31
Capital redemption reserve
2 GBP2024-12-31
Retained earnings (accumulated losses)
-322,411 GBP2024-12-31
Equity
-12,341 GBP2024-12-31
Property, Plant & Equipment - Depreciation rate used
Plant and equipment
252023-10-24 ~ 2024-12-31
Office equipment
332023-10-24 ~ 2024-12-31
Computers
502023-10-24 ~ 2024-12-31
Property, Plant & Equipment - Gross Cost
Plant and equipment
16,257 GBP2024-12-31
Office equipment
960 GBP2024-12-31
Computers
2,375 GBP2024-12-31
Property, Plant & Equipment - Gross Cost
19,592 GBP2024-12-31
Property, Plant & Equipment - Increase From Depreciation Charge for Year
Owned/Freehold
5,006 GBP2023-10-24 ~ 2024-12-31
Property, Plant & Equipment - Accumulated Depreciation & Impairment
Plant and equipment
4,079 GBP2024-12-31
Office equipment
160 GBP2024-12-31
Computers
767 GBP2024-12-31
Property, Plant & Equipment - Accumulated Depreciation & Impairment
5,006 GBP2024-12-31
Property, Plant & Equipment
Plant and equipment
12,178 GBP2024-12-31
Office equipment
800 GBP2024-12-31
Computers
1,608 GBP2024-12-31
Other Debtors
Current
48,556 GBP2024-12-31
Prepayments/Accrued Income
Current
26,175 GBP2024-12-31
Number of Shares Issued (Fully Paid)
Class 1 ordinary share
112,771 shares2024-12-31
Par Value of Share
Class 1 ordinary share
0.0012023-10-24 ~ 2024-12-31

  • PLURIFY LTD
    Info
    Registered number 15230383
    icon of addressSalisbury House, Station Road, Cambridge CB1 2LA
    PRIVATE LIMITED COMPANY incorporated on 2023-10-24 (2 years 2 months). The company status is Active.
    The last date of confirmation statement was made at 2024-10-23
    CIF 0
child relation
Offspring entities and appointments
Active 0
  • Not found in our database.

The content of this website is protected by AgonGuard.

© 2022- Polylogarithmic Technology Ltd (Registered in England and Wales No. 14256313). All rights reserved.

Contains public sector information retrieved at 12 November 2025 and licensed under the Open Government Licence v3.0.